Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Chinese Adults With Kidney Disease — Stella

Home/Immunoglobulin A Nephropathy (IgAN)/Chinese Adults With Kidney Disease

View on ClinicalTrials.gov

Recruiting

Back to Immunoglobulin A Nephropathy (IgAN) trials

Chinese Adults With Kidney Disease

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

China

ADARx Clinical Site, Shenzhen, Guangdong

ADARx Clinical Site, Baotou, Inner Mongolia

ADARx Clinical Site, Wuxi, Jiangsu

ADARx Clinical Site, Yantai, Shandong

ADARx Clinical Site, Beijing

Key details

Phase

Safety & dosing

Sponsor

ADARx Pharmaceuticals, Inc.

Enrollment target

~30 participants

Started

July 2026

Primary completion

July 2028

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.